Studies have shown that the expression level of CXCL5 is significantly upregulated in various inflammatory diseases, such as rheumatoid arthritis, inflammatory bowel disease, kidney diseases and liver ischemia–reperfusion injury14–17. Here, CXCL5 is linked to inflammatory bowel disease.